Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Opdualag From BMS Is Certified By The EC To Cure Melanoma

      FDA Approvals
      The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for use as the first-line...

      Bluebird Bio Breaks Its Own Mark With $3mn Gene Therapy

      Drug Development
      Within one firm, the title of most costly treatment in the world has changed hands within a month. Bluebird Bio has received an FDA fast...

      Neuron23, QIAGEN To Create First Next-Gen Parkinson’s Drug

      Drug Development
      QIAGEN and Neuron23TM Inc., an early-stage biotechnology company focused on creating precision medications for genetically defined neurological and immunological illnesses, have announced a partnership...

      Australia Gives Nod To A New Cholangiocarcinoma Treatment

      FDA Approvals
      Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The Therapeutic Goods Administration...

      CHMP Endorses Beyfortusfrom Sanofi And Astrazenecas For RSV

      FDA Approvals
      Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to treat lower respiratory tract...

      canSERV Offers Cancer Research Solutions Throughout Europe

      News
      Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business...

      Use of 2 COVID Therapies Is Highly Discouraged By The WHO

      Drug Development
      The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and the variant's most recent...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.